hotspot -WSS

hotspot

author：focus 2025-10-02 01:04:42 - browse：98568

Kara Coluccio, a managing partner at Perspective Group poses for a portrait. -- health coverage from STAT — Kara Coluccio, a managing partner at Perspective Group, says the job market for biotech executives has gotten much tighter. Jessica Rinaldi/Globe Staff

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup.

Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy. But pharmaceutical companies are large and complex, and she craved more immediate impact. “I was looking for a place where I could be in the room,” she says. She wanted more autonomy, and to feel like her work would reach patients sooner.

At the time, biotech startups were rolling in cash and seeking to capture some of the magic that had fueled Moderna’s meteoric rise. They handed out lots of logo-embossed swag. “Investors were putting a lot of money into stupid science,” Byers says. “There were a lot of companies that lasted for a lot longer than I thought they would on very little data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Focused ultrasound for uterine fibroids: an uphill battle

knowledge

WSS

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

ACIP vaccine advisory panel sees its vacancies filled

Study gives hint on South Asians’ higher risk of cardiovascular disease

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Startling documents reveal new facets of Sacklers' opioid empire

First Opinion Podcast: What happens when kids become caregivers?

knowledge

hotspot

focus

Medical records are filled with copy

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Virginia high school admissions case could be legal follow

Bernie Sanders gets little from pharma CEOs on drug prices

Tori Bowie and the unacceptable rates of Black maternal death

Why don't Americans have at

Supreme Court strikes down use of affirmative action

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Anesthesiologist group: stop taking Ozempic before surgery

Latigo launches with $135 million for Vertex

focus

Latigo launches with $135 million for Vertex

Why Eli Lilly’s earnings didn’t quite live up to the hype

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Wikipedia

hotspot

knowledge

hotspot